About Hyris
Hyris is a Healthcare company based in London (United Kingdom) founded in 2014. Integrated genetic testing platform with cloud-based analysis is provided. Hyris has raised $2.84 million across 2 funding rounds from investors including Indena, Astanor and NEOS Medica. Its chief executive, as recorded, is Stefano Lo Priore. Hyris offers products and services including Hyris Systemâ„¢, qPCR Devices, and AI Software. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its legal entity is HYRIS LIMITED.
Company details
Hyris was founded in 2014 in London, United Kingdom. An integrated platform for genetic testing of biological samples has been developed, featuring the compact bCUBE 2.0 for data analysis. Real-time results are recorded on the cloud-based Hyris bAPP, which controls the platform for Real-Time PCR and isothermal protocols. Services are extended to the medical, veterinary, and agrofood sectors through this technology.
- Total Equity Funding$2.84M (USD)
in 2 rounds
- Latest Funding Round$2.84M (USD), Series A
Jun 2020
- InvestorsIndena
& 4 more
Products & Services of Hyris
Hyris offers a comprehensive portfolio of products and services, including Hyris System™, qPCR Devices, and AI Software.
Multi-market platform for genetic testing and marketplace transactions
Miniaturized devices for superior genetic analysis performance
Cloud-based platform for operating and gaining testing insights
Apps and channels of Hyris
its YouTube channel Hyris has 200 subscribers and 22 videos.
Videos from Hyris
The most watched videos on Hyris's YouTube channel, Hyris (200 subscribers). Click a video to play it here.
More on Hyris.
Funding Insights of Hyris
Hyris has successfully raised a total of $2.84M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.84 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.84M
- Total Rounds 2
- Last Round Series A — $2.84M
- First Round $11,561
(Jul 2017)
- Investors Count 5
All 2 funding rounds of Hyris with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2020 | $2.84M | Series A | – | Astanor | |
| Jul 2017 | $11,561 | Grant | – | – |
5 investors in total: 5 institutional.
Investors in Hyris
Hyris has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Indena, Astanor and NEOS Medica.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Astanor is focused on transforming the agrifood system through investments. | astanor.com | |||
Early-stage AI startups are funded and supported by Pi Campus. | picampus.it | Rome, Italy | ||
| unicreditstartlab.eu | ||||
Provides medical devices for gastroenterology, endoscopy, and urology diagnostics. | 2018 | neosmedica.com | Trezzano Sul Naviglio, Italy | |
Developer of botanical derivatives for pharmaceuticals and nutraceuticals | 1921 | indena.com | Milan, Italy |
Investor details for Hyris
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Hyris
14 people are tracked at Hyris (6 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Stefano Lo Priore | CEO | Leadership |
Alberto Amati | Co-Founder | Leadership |
Pietro Chiaffoni | Chief Hardware Engineering | Leadership |
Nicola Basile | Chief Financial Officer | Leadership |
Giuseppe Fiore | Head Of Software Development | Leadership |
Lorenzo Colombo | CTO, General Manager | Leadership |
Giuseppe Nicoletti | Production Manager | Team |
Andrea Teofilo | Software Developer | Team |
Erica Vaiani | Verification & Validation (V&V) Manager | Team |
Angelica Baccanelli | Quality and Regulatory Manager | Team |
Gianluca B. | Business Development Representative | Team |
Francesco Buongiorno | Design & Development Manager | Team |
Simone Romano | Product Manager | Team |
Manasjyoti Bhuyan | Embedded Software Engineer | Team |
Complete people profiles for Hyris
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Hyris
3 dated milestones of Hyris across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Hyris is founded.
- Funding First funding round of $12K.
- Funding Latest funding round, Series A, of $2.8M.
Top companies in Genomics & Gene Therapy Platforms
2 companies that operate in the same segment as Hyris (Genomics & Gene Therapy Platforms) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hyris
Complete news archive for Hyris
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hyris
Hyris was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Hyris is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Stefano Lo Priore is the CEO of Hyris, as recorded in our data.
Hyris is a funded company, having raised a total of $2.84M across 2 funding rounds to date. The company's 1st funding round was a Grant of $11.56K, raised on Jul 2017.
Hyris was founded in 2014 in London, United Kingdom. An integrated platform for genetic testing of biological samples has been developed, featuring the compact bCUBE 2.0 for data analysis. Real-time results are recorded on the cloud-based Hyris bAPP, which controls the platform for Real-Time PCR and isothermal protocols. Services are extended to the medical, veterinary, and agrofood sectors through this technology.
Hyris offers Hyris Systemâ„¢, qPCR Devices, and AI Software.
Hyris has 5 investors. Key investors include Indena, Astanor, NEOS Medica, Pi Campus, and UniCredit Start Lab.
Hyris operates through Hyris Limited.